Clinical Trial

Evaluation of Trigeminal Nerve Blockade

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Cleft palate repair requires high doses of opioids for pain control postop. An alternative approach is placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve \& covering the entire midface. Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve may provide effective analgesia for cleft lip repair, improving time to oral intake, pain control and time to hospital discharge.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-05-31 -> 2027-05-31 2026-07-22
Trial Details
NCT Number NCT03632044
Lead Sponsor University of Florida
Conditions Mouth Abnormalities, Cleft Palate, Birth Defect
Enrollment 40 participants
Start Date 2018-11-20
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-21